Related Experiment Video

Updated: Dec 12, 2025

Empirical, Metagenomic, and Computational Techniques Illuminate the Mechanisms by which Fungicides Compromise Bee Health
08:36

Empirical, Metagenomic, and Computational Techniques Illuminate the Mechanisms by which Fungicides Compromise Bee Health

Published on: October 9, 2017

10.1K

Bee product efficacy in children with upper respiratory tract infections

Yılmaz Seçilmiş1, Sibel Silici2

  • 1Division of Pediatric Emergency, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri.

The Turkish Journal of Pediatrics
|August 12, 2020
PubMed

Insights

Bee products effectively treat upper respiratory tract infections (URTIs) in children. This natural remedy offers a safe and cost-effective alternative to conventional treatments with fewer side effects.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Natural Products

Background:

  • Acute upper respiratory tract infection (URTI) is the most common childhood illness.
  • Symptomatic treatments, particularly antitussives, are widely used.
  • Bee products like propolis, royal jelly, and honey possess antiviral, antibacterial, and antioxidant properties.

Purpose of the Study:

  • To assess the efficacy of a bee product mixture for treating URTI in children.
  • To compare the effectiveness of bee products against placebo and standard treatments.

Main Methods:

  • A study involving 104 children aged 5-12 years with URTI.
  • Patients were divided into bacterial and viral infection groups, receiving antibiotics or placebo, with or without bee products.
  • Disease severity and improvement were measured using the Canadian Acute Respiratory Illness and Flu Scale (CARIFS).

Main Results:

  • Children with viral infections showed faster improvement with the bee product mixture compared to placebo.
  • The antibiotic + bee product group had significantly lower CARIFS scores on days 2 and 4 versus antibiotics alone.
  • No adverse reactions or side effects were reported with the bee product mixture.

Conclusions:

  • Bee products demonstrate effectiveness in the symptomatic management of pediatric URTIs.
  • Bee products present a viable, cost-effective, and safer treatment option compared to existing pediatric medications for URTI.
  • The synergistic effects of bee products with antibiotics warrant further investigation.
Abstract

Keywords:
honeypropolisroyal jellyupper respiratory tract infection

More Related Videos

Evaluating the Effect of Environmental Chemicals on Honey Bee Development from the Individual to Colony Level07:39

Evaluating the Effect of Environmental Chemicals on Honey Bee Development from the Individual to Colony Level

Published on: April 1, 2017

9.4K
Video Tracking Protocol to Screen Deterrent Chemistries for Honey Bees10:19

Video Tracking Protocol to Screen Deterrent Chemistries for Honey Bees

Published on: June 12, 2017

6.9K

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
514
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
756
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
781
Upper Respiratory Drugs: Decongestants01:27

Upper Respiratory Drugs: Decongestants

Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
633
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
890
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
1.6K